comprehensive -WSS

comprehensive

author：explore 2025-09-30 15:16:49 - browse：56143

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

WSS

Medicare Advantage plans can’t deny care with AI, CMS warns

Pennsylvania man bitten on the head by bear during attack in his garage

Sage considers ways to reduce costs following FDA rejection

Gene therapy for Afghan refugees’ infant will be fully covered

How CRISPR works, explained in two minutes

Why CTE doesn’t keep Americans from enjoying the Super Bowl

explore

comprehensive

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The CDC's new social media misinformation war

In age of alternative facts, a scholarly course on calling out crap

Judge in Trump's classified documents case questions use of out

Affirmative action in medical school literally saved lives

A single Democrat is willing to weaken Medicare negotiation power

BioMarin wins approval for gene therapy to treat hemophilia A

Surgery pushed Ben Carson to fame

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Surgery pushed Ben Carson to fame

leisure time

Paxlovid rebound happens. Why and to whom are still a mystery

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

NFL doctors' conflicts of interest could endanger players, report says

A single Democrat is willing to weaken Medicare negotiation power

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

focus

entertainment

hotspot

hotspot